Status:
COMPLETED
SHARE - Symbicort and Health Economics in a Real Life Evaluation
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
12+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare health-related costs and asthma control in ordinary clinical practice during 12 months for Symbicort® given as a low maintenance dose plus as needed compared to...
Eligibility Criteria
Inclusion
- Signed informed consent,
- asthma,
- previously treated with glucocorticosteroids and B2-agonist
Exclusion
- History of smoking, pregnancy, any significant disease or disorder which may put the patient at risk because of study participation
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
End Date :
May 1 2007
Estimated Enrollment :
1970 Patients enrolled
Trial Details
Trial ID
NCT00259766
Start Date
April 1 2004
End Date
May 1 2007
Last Update
January 24 2011
Active Locations (108)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Alingsås, Sweden
2
Research Site
Angered, Sweden
3
Research Site
Arlöv, Sweden
4
Research Site
Arvidsjaur, Sweden